Business Wire

Signum Surgical Granted FDA De Novo Clearance for BioHealx

Novel surgical option for the treatment of anal fistula, a painful and debilitating colorectal condition Milestone follows recent completion of clinical trial evaluating the safety and efficacy of the ...
Business Wire

Signum Surgical Appoints Carol Burns as CEO

- Medtech expert to drive commercialization of BioHealx ® for the treatment of anal fistula. GALWAY, Ireland--(BUSINESS WIRE)--Signum Surgical, (‘Signum’ or ‘the Company’) the medical technology ...
Morningstar

Northwell’s Staten Island University Hospital Performs First U.S. Procedure With New BioHealx Device for Complex Anal Fistulas

Northwell's Staten Island University colorectal surgery team celebrates the milestone surgery. The BioHealx device, developed by Irish-based Signum Surgical, represents a significant advancement in ...
Seeking Alpha

Signum Surgical Publishes Positive First-in-Human Results for BioHealx® Anal Fistula Device

Pivotal data supports U.S. FDA De Novo clearance and sets the stage for U.S. launch GALWAY, Ireland--(BUSINESS WIRE)-- Signum Surgical, a medical technology company dedicated to advancing the ...